Dataset: The Plasma Cell Signature in Autoimmune Disease
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
- Species:
- human
- Samples:
- 135
- Source:
- E-GEOD-45537
- Updated:
- Dec.12, 2014
- Registered:
- Jul.12, 2014
Factors:
(via ArrayExpress)
| Sample | TIME | TREATMENT | CELL TYPE | MARKERS | PHENOTYPE |
|---|---|---|---|---|---|
| GSM1108272 | Day 85 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM110827 | Day 29 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108270 | Day 3 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108269 | Day 1 (pre-dose) | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108272 | Day 85 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM110827 | Day 29 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108270 | Day 3 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108269 | Day 1 (pre-dose) | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108264 | Day 85 | placebo | not specified | not specified | scleroderma subject |
| GSM1108263 | Day 29 | placebo | not specified | not specified | scleroderma subject |
| GSM1108262 | Day 3 | placebo | not specified | not specified | scleroderma subject |
| GSM110826 | Day 1 (pre-dose) | placebo | not specified | not specified | scleroderma subject |
| GSM1108272 | Day 85 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM110827 | Day 29 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108270 | Day 3 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108269 | Day 1 (pre-dose) | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108272 | Day 85 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM110827 | Day 29 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108270 | Day 3 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108269 | Day 1 (pre-dose) | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108272 | Day 85 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM110827 | Day 29 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108270 | Day 3 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108269 | Day 1 (pre-dose) | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108272 | Day 85 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM110827 | Day 29 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108270 | Day 3 | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108269 | Day 1 (pre-dose) | 10.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108264 | Day 85 | placebo | not specified | not specified | scleroderma subject |
| GSM1108263 | Day 29 | placebo | not specified | not specified | scleroderma subject |
| GSM1108262 | Day 3 | placebo | not specified | not specified | scleroderma subject |
| GSM110826 | Day 1 (pre-dose) | placebo | not specified | not specified | scleroderma subject |
| GSM1108240 | Day 85 | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108239 | Day 29 | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108238 | Day 3 | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108237 | Day 1 (pre-dose) | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108240 | Day 85 | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108239 | Day 29 | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108238 | Day 3 | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108237 | Day 1 (pre-dose) | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108240 | Day 85 | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108239 | Day 29 | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108238 | Day 3 | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108237 | Day 1 (pre-dose) | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108239 | Day 29 | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108238 | Day 3 | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108237 | Day 1 (pre-dose) | 3.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108264 | Day 85 | placebo | not specified | not specified | scleroderma subject |
| GSM1108263 | Day 29 | placebo | not specified | not specified | scleroderma subject |
| GSM1108262 | Day 3 | placebo | not specified | not specified | scleroderma subject |
| GSM110826 | Day 1 (pre-dose) | placebo | not specified | not specified | scleroderma subject |
| GSM110822 | Day 85 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108220 | Day 29 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108219 | Day 3 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108218 | Day 1 (pre-dose) | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM110822 | Day 85 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108220 | Day 29 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108219 | Day 3 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108218 | Day 1 (pre-dose) | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM110822 | Day 85 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108220 | Day 29 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108219 | Day 3 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108218 | Day 1 (pre-dose) | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM110822 | Day 85 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108220 | Day 29 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108219 | Day 3 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108218 | Day 1 (pre-dose) | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM110822 | Day 85 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108220 | Day 29 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108219 | Day 3 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108218 | Day 1 (pre-dose) | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM110822 | Day 85 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108220 | Day 29 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108219 | Day 3 | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108218 | Day 1 (pre-dose) | 1.0 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108197 | Day 85 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108196 | Day 29 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108195 | Day 3 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108194 | Day 1 (pre-dose) | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108197 | Day 85 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108196 | Day 29 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108195 | Day 3 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108194 | Day 1 (pre-dose) | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108197 | Day 85 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108196 | Day 29 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108195 | Day 3 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108194 | Day 1 (pre-dose) | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108197 | Day 85 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108196 | Day 29 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108195 | Day 3 | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108194 | Day 1 (pre-dose) | 0.3 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108264 | Day 85 | placebo | not specified | not specified | scleroderma subject |
| GSM1108263 | Day 29 | placebo | not specified | not specified | scleroderma subject |
| GSM1108262 | Day 3 | placebo | not specified | not specified | scleroderma subject |
| GSM110826 | Day 1 (pre-dose) | placebo | not specified | not specified | scleroderma subject |
| GSM1108177 | Day 85 | 0.1 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108176 | Day 29 | 0.1 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108175 | Day 3 | 0.1 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108174 | Day 1 (pre-dose) | 0.1 mpk MEDI-551 | not specified | not specified | scleroderma subject |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108173 | NA | NA | not specified | not specified | healthy donor |
| GSM1108149 | not specified | not specified | T cells | CD3+ | not specified |
| GSM1108148 | not specified | not specified | Plasma cells | CD38+CD27+ | not specified |
| GSM1108147 | not specified | not specified | monocytes | CD14+ | not specified |
| GSM1108146 | not specified | not specified | Granulocytes | CD15+ | not specified |
| GSM1108145 | not specified | not specified | B Cells | CD19+CD20+ | not specified |
| GSM1108144 | not specified | not specified | whole blood | NA | not specified |
| GSM1108149 | not specified | not specified | T cells | CD3+ | not specified |
| GSM1108148 | not specified | not specified | Plasma cells | CD38+CD27+ | not specified |
| GSM1108147 | not specified | not specified | monocytes | CD14+ | not specified |
| GSM1108146 | not specified | not specified | Granulocytes | CD15+ | not specified |
| GSM1108145 | not specified | not specified | B Cells | CD19+CD20+ | not specified |
| GSM1108144 | not specified | not specified | whole blood | NA | not specified |